Nic J G M Veeger

Author PubWeight™ 86.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Compliance in heart failure patients: the importance of knowledge and beliefs. Eur Heart J 2005 2.81
2 Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials. JAMA 2006 2.38
3 Microalbuminuria and risk of venous thromboembolism. JAMA 2009 2.35
4 Design and methodology of the COACH study: a multicenter randomised Coordinating study evaluating Outcomes of Advising and Counselling in Heart failure. Eur J Heart Fail 2004 2.30
5 High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation 2007 2.07
6 Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood 2009 1.93
7 Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study. J Am Coll Cardiol 2005 1.71
8 Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: results from the RAte Control versus Electrical cardioversion (RACE) study. Am Heart J 2005 1.71
9 High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin. Thromb Haemost 2009 1.64
10 Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception. Blood 2011 1.63
11 Compliance with non-pharmacological recommendations and outcome in heart failure patients. Eur Heart J 2010 1.60
12 Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts. Circulation 2012 1.59
13 Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: results from the RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) study. Heart Rhythm 2005 1.52
14 Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A. Circulation 2010 1.50
15 Does flecainide regain its antiarrhythmic activity after electrical cardioversion of persistent atrial fibrillation? Heart Rhythm 2005 1.42
16 Evaluation of 1025 fetal deaths: proposed diagnostic workup. Am J Obstet Gynecol 2011 1.42
17 Long-term quality of VKA treatment and clinical outcome after extreme overanticoagulation in 14,777 AF and VTE patients. Thromb Haemost 2014 1.40
18 Thrombogenicity and reoperation of the St. Jude Medical Silzone valve: a comparison with the conventional St. Jude Medical valve. J Heart Valve Dis 2003 1.38
19 The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus. Blood 2004 1.20
20 Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 years. J Endovasc Ther 2007 1.18
21 Cytogenetic analysis after evaluation of 750 fetal deaths: proposal for diagnostic workup. Obstet Gynecol 2008 1.17
22 Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme. Br J Haematol 2011 1.13
23 Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patients. J Hematol Oncol 2013 1.09
24 Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study. Circulation 2008 1.07
25 For better and for worse: Quality of life impaired in HF patients as well as in their partners. Eur J Cardiovasc Nurs 2005 1.05
26 Epstein-Barr virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression. Transplantation 2007 1.02
27 High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia. Blood 2010 1.01
28 An observational, prospective, two-cohort comparison of a fixed versus variable dosing strategy of prothrombin complex concentrate to counteract vitamin K antagonists in 240 bleeding emergencies. Haematologica 2012 0.98
29 Diverse placental pathologies as the main causes of fetal death. Obstet Gynecol 2009 0.98
30 Treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone is beneficial but toxic in very elderly patients with diffuse large B-cell lymphoma: a population-based cohort study on treatment, toxicity and outcome. Leuk Lymphoma 2013 0.95
31 AML at older age: age-related gene expression profiles reveal a paradoxical down-regulation of p16INK4A mRNA with prognostic significance. Blood 2009 0.94
32 Early onset post-transplant lymphoproliferative disease is associated with allograft localization. Clin Transplant 2005 0.94
33 A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families. Blood 2009 0.92
34 A prospective randomized trial comparing stenting with off-pump coronary surgery for high-grade stenosis in the proximal left anterior descending coronary artery: three-year follow-up. J Am Coll Cardiol 2002 0.92
35 HLA antigens and post renal transplant lymphoproliferative disease: HLA-B matching is critical. Transplantation 2005 0.90
36 In normal controls, both age and gender affect coagulability as measured by thrombelastography. Anesth Analg 2010 0.90
37 RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II. Am Heart J 2006 0.89
38 Minimally invasive coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty with stenting in isolated high-grade stenosis of the proximal left anterior descending coronary artery: six months' angiographic and clinical follow-up of a prospective randomized study. J Thorac Cardiovasc Surg 2002 0.89
39 Isolated high-grade lesion of the proximal LAD: a stent or off-pump LIMA? Eur J Cardiothorac Surg 2004 0.88
40 Endothelial dysfunction in patients with coronary artery disease: a comparison of three frequently reported tests. J Investig Med 2002 0.88
41 Diurnal variation of ventricular repolarization in a large family with LQT3-Brugada syndrome characterized by nocturnal sudden death. Heart Rhythm 2006 0.86
42 Assessing the prognostic value of coronary endothelial function in patients referred for a first coronary angiogram. Am J Cardiol 2004 0.85
43 Difference in absolute risk of venous and arterial thrombosis between familial protein S deficiency type I and type III. Results from a family cohort study to assess the clinical impact of a laboratory test-based classification. Br J Haematol 2005 0.85
44 Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study. Arch Intern Med 2007 0.84
45 Comorbidity is an independent prognostic factor in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP: a population-based cohort study. Br J Haematol 2014 0.84
46 Correlates of endothelial function and their relationship with inflammation in patients with familial hypercholesterolaemia. Clin Sci (Lond) 2003 0.84
47 The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defects. Thromb Haemost 2007 0.83
48 Absolute annual incidences of first events of venous thromboembolism and arterial vascular events in individuals with elevated FVIII:c. A prospective family cohort study. Thromb Haemost 2007 0.83
49 Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial. Arch Dermatol 2006 0.83
50 Clinical relevance of decreased free protein S levels: results from a retrospective family cohort study involving 1143 relatives. Blood 2008 0.82
51 Different risk of deep vein thrombosis and pulmonary embolism in carriers with factor V Leiden compared with non-carriers, but not in other thrombophilic defects. Results from a large retrospective family cohort study. Haematologica 2009 0.82
52 Lipid levels do not influence the risk of venous thromboembolism. Results of a population-based cohort study. Thromb Haemost 2012 0.81
53 Exercise-induced ischemia after successful percutaneous coronary intervention is related to distal coronary endothelial dysfunction. J Investig Med 2003 0.81
54 The pathogenesis of venous thromboembolism: evidence for multiple interrelated causes. Ann Intern Med 2006 0.81
55 Associations between high factor VIII and low free protein S levels with traditional arterial thrombotic risk factors and their risk on arterial thrombosis: results from a retrospective family cohort study. Thromb Res 2010 0.81
56 Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels. Thromb Haemost 2008 0.81
57 Increased risk of arterial thromboembolism after a prior episode of venous thromboembolism: results from the Prevention of REnal and Vascular ENd stage Disease (PREVEND) Study. Br J Haematol 2012 0.80
58 Hyperhomocysteinemia is not a risk factor for venous and arterial thrombosis, and is associated with elevated factor VIII levels. Thromb Res 2008 0.80
59 Children with asthma have significantly lower long-term cortisol levels in their scalp hair than healthy children. Acta Paediatr 2014 0.80
60 Right atrial preventive and antitachycardia pacing for prevention of paroxysmal atrial fibrillation in patients without bradycardia: a randomized study. Europace 2008 0.80
61 Determination of vessel size: a putative framework to assess clinical outcome. Int J Cardiol 2004 0.80
62 Possible contribution of cytomegalovirus infection to the high risk of (recurrent) venous thrombosis after renal transplantation. Thromb Haemost 2008 0.79
63 Comparison of late (four years) functional health status between percutaneous transluminal angioplasty intervention and off-pump left internal mammary artery bypass grafting for isolated high-grade narrowing of the proximal left anterior descending coronary artery. Am J Cardiol 2004 0.79
64 High risk of pregnancy-related venous thromboembolism in women with multiple thrombophilic defects. Br J Haematol 2007 0.79
65 Elevated albuminuria associated with increased risk of recurrent venous thromboembolism: results of a population-based cohort study. Br J Haematol 2012 0.79
66 Contribution of multiple thrombophilic and transient risk factors in the development of cerebral venous thrombosis. Thromb Res 2007 0.78
67 Minimally invasive bypass surgery. N Engl J Med 2002 0.78
68 The risk of postpartum hemorrhage in women using high dose of low-molecular-weight heparins during pregnancy. Thromb Res 2012 0.78
69 Mending the rhythm does not improve prognosis in patients with persistent atrial fibrillation: a subanalysis of the RACE study. Eur Heart J 2005 0.78
70 Statin use in patients with nephrotic syndrome is associated with a lower risk of venous thromboembolism. Thromb Res 2011 0.77
71 Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women. Br J Haematol 2007 0.77
72 Coronary vasomotor response is related to the angiographic extent of coronary sclerosis in patients with stable angina pectoris. Clin Sci (Lond) 2004 0.77
73 Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation. J Am Coll Cardiol 2006 0.77
74 Clinical characteristics of persistent lone atrial fibrillation in the RACE study. Am J Cardiol 2004 0.77
75 A low fixed dose of prothrombin complex concentrate is cost effective in emergency reversal of vitamin K antagonists. Haematologica 2013 0.76
76 Protein S type III deficiency is no risk factor for venous and arterial thromboembolism in 168 thrombophilic families: a retrospective study. Blood Coagul Fibrinolysis 2005 0.76
77 Diagnostic utility of (18)F-FDG PET/CT in inflammation of unknown origin. Clin Nucl Med 2014 0.75
78 Screening tool does not select for bleeding disorders in women with menorrhagia. Am J Obstet Gynecol 2011 0.75
79 Catheter-directed thrombolysis for acute deep vein thrombosis. Lancet 2012 0.75
80 [Clipping comparable to coiling in intracranial aneurysm]. Ned Tijdschr Geneeskd 2015 0.75
81 HLA matching and posttransplant lymphoproliferative disease after lung transplantation. Transplantation 2005 0.75
82 The predictive value of C-reactive protein and erythrocyte sedimentation rate for 18F-FDG PET/CT outcome in patients with fever and inflammation of unknown origin. Nucl Med Commun 2015 0.75
83 Prevalence of parental thrombophilic defects after fetal death and relation to cause. Obstet Gynecol 2010 0.75
84 Low absolute risk of venous and arterial thrombosis in hyperhomocysteinaemia - a prospective family cohort study in asymptomatic subjects. Thromb Haemost 2009 0.75
85 [Prevalence of gestational diabetes in high-risk pregnancies: screened using an oral glucose tolerance test]. Ned Tijdschr Geneeskd 2013 0.75
86 Attenuated salivary cortisol response after exercise test in children with asthma. J Pediatr Endocrinol Metab 2015 0.75
87 Thrombin activatable fibrinolysis inhibitor (TAFI) is not associated with fetal loss, a retrospective study. Thromb Res 2008 0.75
88 The risk of venous and arterial thrombosis in hyperhomocysteinemic subjects may be a result of elevated factor VIII levels. Haematologica 2007 0.75